CC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.6B
+15.2%
1.4B
+3.8%
1.3B
-11.0%
1.5B
-7.4%
1.6B
Cost of Revenue
1.3B
+11.6%
1.2B
-0.4%
1.2B
-7.0%
1.3B
-5.6%
1.3B
Gross Profit
286.0M
+34.9%
212.0M
+35.9%
156.0M
-33.0%
233.0M
-16.2%
278.0M
Operating Expenses
499.0M
+168.3%
186.0M
+15.5%
161.0M
+15.8%
139.0M
-70.4%
470.0M
R&D
27.0M
+3.8%
26.0M
-3.7%
27.0M
+3.8%
26.0M
-7.1%
28.0M
SG&A
469.0M
+219.0%
147.0M
+13.1%
130.0M
+19.3%
109.0M
-74.3%
424.0M
Operating Income
-213000000
-919.2%
26.0M
+620.0%
-5000000
-105.3%
94.0M
+149.0%
-192000000
EBITDA
-130000000
-210.2%
118.0M
+47.5%
80.0M
-54.8%
177.0M
+315.9%
-82000000
Net Income
-274000000
-844.8%
-29000000
+53.2%
-62000000
-203.3%
60.0M
+115.8%
-379000000
EPS (Basic)
$-1.81
-852.6%
$-0.19
+53.7%
$-0.41
-202.5%
$0.40
+115.8%
$-2.53
EPS (Diluted)
$-1.81
-852.6%
$-0.19
+53.7%
$-0.41
-202.5%
$0.40
+115.8%
$-2.53
Shares (Diluted)
151.2M
+0.3%
150.8M
+0.5%
150.0M
-0.5%
150.8M
+0.4%
150.2M
The Chemours (CC) โ€” Financials